1. Dexmedetomidine attenuates one‐lung ventilation associated lung injury by suppressing inflammatory responses: A systematic review and meta‐analysis
   Yun‐Xiao Bai et al, 2021, Clinical and Experimental Pharmacology and Physiology CrossRef
2. A Peptide Inhibitor of Peroxiredoxin 6 Phospholipase A2 Activity Significantly Protects against Lung Injury in a Mouse Model of Ventilator Induced Lung Injury (VILI)
   Aron B. Fisher et al, 2021, Antioxidants CrossRef
3. Comparison of Dexmedetomidine Versus Propofol in Mechanically Ventilated Patients With Sepsis: A Meta-Analysis of Randomized Controlled Trials
   Hua-Ze Ding et al, 2022, Frontiers in Pharmacology CrossRef
4. Dexmedetomidine improves pulmonary outcomes in thoracic surgery under one-lung ventilation: A meta-analysis
   Andres Zorrilla-Vaca et al, 2024, Journal of Clinical Anesthesia CrossRef
5. Dexmedetomidine hydrochloride inhibits hepatocyte apoptosis and inflammation by activating the lncRNA TUG1/miR-194/SIRT1 signaling pathway
   Xiao-Xia Gu et al, 2021, Journal of Inflammation CrossRef
6. Dexmedetomidine reduces IL-4 and IgE expression through downregulation of theTLR4/NF-κB signaling pathway to alleviate airway hyperresponsiveness in OVA mice
   Juan Zhi et al, 2022, Pulmonary Pharmacology & Therapeutics CrossRef
7. Future directions in ventilator-induced lung injury associated cognitive impairment: a new sight
   Yinuo Liu et al, 2023, Frontiers in Physiology CrossRef
8. Role of EGF/ERK1/2/HO-1 axis in mediating methotrexate induced testicular damage in rats and the ameliorative effect of xanthine oxidase inhibitors
   Remon Roshdy Rofaeil et al, 2023, Immunopharmacology and Immunotoxicology CrossRef
9. Using the sympathetic system, beta blockers and alpha-2 agonists, to address acute respiratory distress syndrome
   Yiyuan Yin et al, 2024, International Immunopharmacology CrossRef